Shefali Agarwal's Net Worth
$149 Thousand
Who is Shefali Agarwal?
Shefali Agarwal does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Gritstone bio, Inc., FATE THERAPEUTICS INC, and Epizyme, Inc..
SEC CIK
Shefali Agarwal's CIK is 0001746830
Past Insider Trading and Trends
2019 was Shefali Agarwal's most active year for acquiring shares with 8 total transactions. Shefali Agarwal's most active month to acquire stocks was the month of May. 2022 was Shefali Agarwal's most active year for disposing of shares, totalling 12 transactions. Shefali Agarwal's most active month to dispose stocks was the month of July. 2022 saw Shefali Agarwal paying a total of $697,952.21 for 1,041,874 shares, this is the most they've acquired in one year. In 2022 Shefali Agarwal cashed out on 1,167,960 shares for a total of $566,598.02, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Gritstone bio, Inc. (GRTS) Snapshot price: $0.47
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
FATE THERAPEUTICS INC (FATE) Snapshot price: $3.41
InvestorShefali Agarwal owns 10,490 units of Common Stock which is worth $35,770.90. From 2019 to 2024 Shefali Agarwal acquired a total of 11,331 shares in FATE THERAPEUTICS INC, Shefali also disposed a total of 1,648 shares of FATE THERAPEUTICS INC equalling to $36,809.09.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
| +470.11% | 8.65K |
—
|
—
| 10.49K |
Jun 9
| |||
Form 4
| -31.37% | -841.00 |
$21.89 | -$18,409.49 | 1.84K |
Jun 7
| |||
Form 4/A
|
—
|
0
|
—
|
—
| 2.68K |
Jun 3
| |||
Form 4
| -30.10% | -807.00 |
$22.80 | -$18,399.60 | 1.87K |
Jun 3
| |||
Form 4
|
∞
| 2.68K |
—
|
—
| 2.68K |
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Epizyme, Inc. No price found
See RemarksShefali Agarwal owns 158,716 units of Common Stock. Shefali Agarwal used to own units in Common Stock, par value $0.0001 but no longer holds any shares there. In the year 2018 Shefali Agarwal filed a total of 24 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -286.54K |
—
|
—
|
0
|
Aug 12
| |||
Form 4
| +79.92% | 126.85K |
$1.39 | $176,315.94 | 285.56K |
Aug 9
| |||
Form 4
| +1.49% | 2.33K |
$1.27 | $2,952.21 | 158.72K |
Feb 28 - Mar 17
| |||
Form 4
| -0.67% | -1.06K |
$1.50 | -$1,587.00 | 156.38K |
Scheduled
|
Feb 7
| ||
Form 4
| -1.65% | -2.64K |
$1.37 | -$3,615.43 | 157.44K |
Scheduled
|
Feb 2
| ||
Form 4
| -1.79% | -2.92K |
$2.02 | -$5,902.44 | 160.08K |
Scheduled
|
Jan 26
| ||
Form 4
| -1.08% | -1.78K |
$2.93 | -$5,215.40 | 163K |
Scheduled
|
Dec 6
| ||
Form 4
| +56.70% | 59.17K |
—
|
—
| 163.51K |
Aug 16
| |||
Form 4
| -0.92% | -969.00 |
$11.21 | -$10,862.49 | 104.34K |
Scheduled
|
Feb 4
| ||
Form 4
| +39.07% | 29.58K |
—
|
—
| 105.31K |
Feb 1
| |||
Form 4
| -3.65% | -2.87K |
$11.41 | -$32,769.52 | 75.73K |
Scheduled
|
Jan 25
| ||
Form 4
| -3.21% | -2.52K |
$13.54 | -$34,147.88 | 76.09K |
Scheduled
|
Dec 3
| ||
Form 4
| +5.64% | 4.2K |
$16.15 | -$29,150.75 | 78.61K |
Scheduled
|
Jun 25 - Jun 26
| ||
Form 4/A
| +5.68% | 4K |
—
|
—
| 74.42K |
Mar 24
| |||
Form 4
| +0.46% | 332 |
$15.28 | -$18,993.04 | 71.99K |
Scheduled
|
Mar 24 - Mar 25
| ||
Form 4
| +21.86% | 12.86K |
—
|
—
| 71.66K |
Feb 3
| |||
Form 4
| +0.90% | 527 |
$22.17 | -$99,168.72 | 58.8K |
Scheduled
|
Jan 23 - Jan 27
| ||
Form 4/A
| +63.24% | 22.58K |
—
|
—
| 58.28K |
Dec 2
| |||
Form 4
| +63.24% | 22.58K |
—
|
—
| 58.28K |
Dec 2
| |||
Form 4
| -3.24% | -1.20K |
$11.97 | -$14,304.15 | 35.7K |
Scheduled
|
Jun 14
| ||
Form 4
| +12.16% | 4K |
—
|
—
| 36.89K |
Jun 12
| |||
Form 4
|
∞
| 32.89K |
—
|
—
| 32.89K |
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||